{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T21:31:13Z","timestamp":1777671073512,"version":"3.51.4"},"reference-count":79,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100008666","name":"Fundaci\u00f3 la Marat\u00f3 de TV3","doi-asserted-by":"publisher","award":["091710"],"award-info":[{"award-number":["091710"]}],"id":[{"id":"10.13039\/100008666","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003030","name":"AGAUR","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003030","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Clinical Pharmacology and Pharmacogenetics Group","award":["2017 SGR 1562"],"award-info":[{"award-number":["2017 SGR 1562"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain, Behavior, and Immunity"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.bbi.2019.07.022","type":"journal-article","created":{"date-parts":[[2019,7,22]],"date-time":"2019-07-22T01:40:08Z","timestamp":1563759608000},"page":"608-616","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"special_numbering":"C","title":["Altered frequencies of Th17 and Treg cells in children and adolescents with obsessive-compulsive disorder"],"prefix":"10.1016","volume":"81","author":[{"given":"Natalia","family":"Rodr\u00edguez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Astrid","family":"Morer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. Azucena","family":"Gonz\u00e1lez-Navarro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carles","family":"Serra-Pages","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Boloc","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teresa","family":"Torres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albert","family":"Martinez-Pinte\u00f1o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergi","family":"Mas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amalia","family":"Lafuente","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia","family":"Gass\u00f3","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luisa","family":"L\u00e1zaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbi.2019.07.022_b0005","doi-asserted-by":"crossref","first-page":"4390","DOI":"10.1007\/s12035-016-9977-0","article-title":"Dysregulation of Th1, Th2, Th17, and T regulatory cell-related transcription factor signaling in children with autism","volume":"54","author":"Ahmad","year":"2017","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.bbi.2019.07.022_b0010","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jneuroim.2015.07.003","article-title":"Increased production of IL-17 in children with autism spectrum disorders and co-morbid asthma","volume":"286","author":"Akintunde","year":"2015","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.bbi.2019.07.022_b0015","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/1742-2094-9-158","article-title":"Elevated serum levels of interleukin-17A in children with autism","volume":"9","author":"Al-Ayadhi","year":"2012","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.bbi.2019.07.022_b0020","series-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"1994"},{"key":"10.1016\/j.bbi.2019.07.022_b0025","series-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"2013"},{"key":"10.1016\/j.bbi.2019.07.022_b0030","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1084\/jem.20070663","article-title":"Phenotypic and functional features of human Th17 cells","volume":"204","author":"Annunziato","year":"2007","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bbi.2019.07.022_b0035","first-page":"1353","article-title":"Is obsessive-compulsive disorder an autoimmune disease?","volume":"165","author":"Arnold","year":"2001","journal-title":"CMAJ"},{"key":"10.1016\/j.bbi.2019.07.022_b0040","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1001\/jamapsychiatry.2017.1567","article-title":"Inflammation in the neurocircuitry of obsessive-compulsive disorder","volume":"74","author":"Attwells","year":"2017","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.bbi.2019.07.022_b0045","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.psyneuen.2018.05.002","article-title":"Immune aberrations in children with Autism Spectrum Disorder: a case- control study from a tertiary care neuropsychiatric hospital in India","volume":"94","author":"Basheer","year":"2018","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.bbi.2019.07.022_b0050","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jneuroim.2018.03.004","article-title":"The circulating levels of CD4+ t helper cells are higher in bipolar disorder as compared to major depressive disorder","volume":"319","author":"Becking","year":"2018","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.bbi.2019.07.022_b0055","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1038\/nature07036","article-title":"Induction and effector functions of TH 17 cells","volume":"453","author":"Bettelli","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.bbi.2019.07.022_b0060","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/ni0407-345","article-title":"Th-17 cells in the circle of immunity and autoimmunity","volume":"8","author":"Bettelli","year":"2007","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.bbi.2019.07.022_b0065","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.bbi.2017.08.001","article-title":"Th17 cells in depression","volume":"69","author":"Beurel","year":"2018","journal-title":"Brain. Behav. Immun."},{"key":"10.1016\/j.bbi.2019.07.022_b0070","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.231","article-title":"Anti-inflammatory, antiapoptotic, and antioxidant activity of fluoxetine","volume":"4","author":"Caiaffo","year":"2016","journal-title":"Pharmacol. Res. Perspect."},{"key":"10.1016\/j.bbi.2019.07.022_b0075","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2016.30","article-title":"Whole-exome sequencing in obsessivecompulsive disorder identifies rare mutations and immunological pathways","volume":"6","author":"Cappi","year":"2016","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.bbi.2019.07.022_b0080","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1590\/S0004-282X2012000200003","article-title":"Association study between functional polymorphisms in the TNF-alpha gene and obsessive-compulsive disorder","volume":"70","author":"Cappi","year":"2012","journal-title":"Arq. Neuropsiquiatr."},{"key":"10.1016\/j.bbi.2019.07.022_b0085","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1034\/j.1600-0447.2000.102006401.x","article-title":"On the role of cortical glutamate in obsessive-compulsive disorder and attention-deficit hyperactivity disorder, two phenomenologically antithetical conditions","volume":"102","author":"Carlsson","year":"2000","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.bbi.2019.07.022_b0090","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s10875-009-9365-x","article-title":"Plasma IL-17A is increased in new-onset SLE patients and associated with disease activity","volume":"30","author":"Chen","year":"2010","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.bbi.2019.07.022_b0095","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1111\/j.1365-2133.2010.09992.x","article-title":"Interleukin (IL)-22, IL-17, IL-23, IL-8, vascular endothelial growth factor and tumour necrosis factor-\u03b1 levels in patients with psoriasis before, during and after psoralen-ultraviolet A and narrowband ultraviolet B therapy","volume":"163","author":"Coimbra","year":"2010","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.bbi.2019.07.022_b0100","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1192\/bjp.187.4.314","article-title":"Incidence of anti-brain antibodies in children with obsessive-compulsive disorder","volume":"187","author":"Dale","year":"2005","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.bbi.2019.07.022_b0105","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1080\/13651501.2016.1207087","article-title":"Childhood, adolescent and adult age at onset and related clinical correlates in obsessive-compulsive disorder: a report from the International College of Obsessive-Compulsive Spectrum Disorders (ICOCS)","volume":"20","author":"Dell\u2019Osso","year":"2016","journal-title":"Int. J. Psychiatry Clin. Pract."},{"key":"10.1016\/j.bbi.2019.07.022_b0110","doi-asserted-by":"crossref","first-page":"6309219","DOI":"10.1155\/2016\/6309219","article-title":"Balancing inflammation: the link between Th17 and tegulatory T cells","volume":"2016","author":"Diller","year":"2016","journal-title":"Mediators Inflamm."},{"key":"10.1016\/j.bbi.2019.07.022_b0115","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.pnpbp.2014.01.001","article-title":"Activation of Th17 cells in drug na\u00efve, first episode schizophrenia","volume":"51","author":"Ding","year":"2014","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.bbi.2019.07.022_b0120","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.cyto.2018.03.034","article-title":"Cytokine profile in autistic patients","volume":"108","author":"Eftekharian","year":"2018","journal-title":"Cytokine"},{"key":"10.1016\/j.bbi.2019.07.022_b0125","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1155\/2013\/329375","article-title":"Immune dysfunction in Tourette syndrome","volume":"27","author":"Elamin","year":"2013","journal-title":"Behav. Neurol."},{"key":"10.1016\/j.bbi.2019.07.022_b0130","doi-asserted-by":"crossref","first-page":"8606057","DOI":"10.1155\/2016\/8606057","article-title":"Microglial dysregulation in OCD, Tourette syndrome, and PANDAS","volume":"2016","author":"Frick","year":"2016","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.bbi.2019.07.022_b0135","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1007\/s11920-012-0272-0","article-title":"Systematic review of proinflammatory cytokines in obsessive- compulsive disorder","volume":"14","author":"Gray","year":"2012","journal-title":"Curr Psychiatry Rep"},{"key":"10.1016\/j.bbi.2019.07.022_b0140","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1096\/fj.09-141978","article-title":"Cellular mechanisms of IL-17-induced blood-brain barrier disruption","volume":"24","author":"Huppert","year":"2010","journal-title":"FASEB J."},{"key":"10.1016\/j.bbi.2019.07.022_b0145","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.3389\/fimmu.2018.02508","article-title":"Auto-reactive Th17-cells trigger obsessive-compulsive-disorder like behavior in mice with experimental autoimmune encephalomyelitis","volume":"9","author":"Kant","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbi.2019.07.022_b0150","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1097\/00004583-199707000-00021","article-title":"Schedule for affective disorders and schizophrenia for school-age children-present and lifetime version (K-SADS-PL): initial reliability and validity data","volume":"36","author":"Kaufman","year":"1997","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.bbi.2019.07.022_b0155","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jneuroim.2007.11.006","article-title":"Production and functions of IL-17 in microglia","volume":"194","author":"Kawanokuchi","year":"2008","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.bbi.2019.07.022_b0160","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.biopsych.2006.06.012","article-title":"Decreased numbers of regulatory T Cells suggest impaired immune tolerance in children with tourette syndrome: a preliminary study","volume":"61","author":"Kawikova","year":"2007","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.bbi.2019.07.022_b0165","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1038\/nm1651","article-title":"Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation","volume":"13","author":"Kebir","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbi.2019.07.022_b0170","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1177\/0269881112467089","article-title":"A review of anti-inflammatory agents for symptoms of schizophrenia","volume":"27","author":"Keller","year":"2013","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.bbi.2019.07.022_b0175","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-025333","article-title":"Protocol for the insight study: a randomised controlled trial of single-dose tocilizumab in patients with depression and low-grade inflammation","volume":"8","author":"Khandaker","year":"2018","journal-title":"BMJ Open"},{"key":"10.1016\/j.bbi.2019.07.022_b0180","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/sji.12147","article-title":"IL-17 and glutamate excitotoxicity in the pathogenesis of multiple sclerosis","volume":"79","author":"Kostic","year":"2014","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.bbi.2019.07.022_b0185","doi-asserted-by":"crossref","first-page":"149","DOI":"10.3390\/brainsci8080149","article-title":"Individualized immunological data for precise classification of OCD patients","volume":"8","author":"Lamothe","year":"2018","journal-title":"Brain Sci."},{"key":"10.1016\/j.bbi.2019.07.022_b0190","article-title":"Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections (PANDAS): an evolving concept","volume":"3","author":"Macerollo","year":"2013","journal-title":"Tremor Other Hyperkinet. Mov. (N. Y)"},{"key":"10.1016\/j.bbi.2019.07.022_b0195","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1002\/hup.191","article-title":"The immunoregulatory effects of antidepressants","volume":"16","author":"Maes","year":"2001","journal-title":"Hum. Psychopharmacol."},{"key":"10.1016\/j.bbi.2019.07.022_b0200","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1002\/mds.22504","article-title":"Immunopathogenic mechanismsin tourette syndrome: a critical review","volume":"24","author":"Martino","year":"2009","journal-title":"Mov. Disord."},{"key":"10.1016\/j.bbi.2019.07.022_b0205","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.brainres.2014.04.027","article-title":"The role of immune mechanisms in Tourette syndrome","volume":"1617","author":"Martino","year":"2015","journal-title":"Brain Res."},{"key":"10.1016\/j.bbi.2019.07.022_b0210","doi-asserted-by":"crossref","first-page":"547","DOI":"10.3389\/fnins.2018.00547","article-title":"Involvement of innate and adaptive immune systems alterations in the pathophysiology and treatment of depression","volume":"12","author":"Medina-Rodriguez","year":"2018","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.bbi.2019.07.022_b0215","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1192\/bjp.bp.109.075317","article-title":"Long-term outcomes of obsessive-compulsive disorder: follow-up of 142 children and adolescents","volume":"197","author":"Micali","year":"2010","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.bbi.2019.07.022_b0220","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/da.22084","article-title":"Cytokine targets in the brain: impact on neurotransmitters and neurocircuits","volume":"30","author":"Miller","year":"2013","journal-title":"Depress Anxiety"},{"key":"10.1016\/j.bbi.2019.07.022_b0225","doi-asserted-by":"crossref","first-page":"275","DOI":"10.4088\/JCP.15l09920","article-title":"An open-label, pilot trial of adjunctive tocilizumab in Schizophrenia","volume":"77","author":"Miller","year":"2016","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.bbi.2019.07.022_b0230","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.msard.2018.12.013","article-title":"Micro-RNA 18b and interleukin 17A profiles in relapsing remitting multiple sclerosis","volume":"28","author":"Mohamed","year":"2019","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.bbi.2019.07.022_b0235","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jpsychires.2006.09.010","article-title":"Antineuronal antibodies in a group of children with obsessive-compulsive disorder and Tourette syndrome","volume":"42","author":"Morer","year":"2008","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.bbi.2019.07.022_b0240","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jpsychires.2005.04.003","article-title":"Subtyping obsessive-compulsive disorder: clinical and immunological findings in child and adult onset","volume":"40","author":"Morer","year":"2006","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.bbi.2019.07.022_b0245","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1177\/0883073809339393","article-title":"Frequency of CD4+CD25high regulatory T cells in the peripheral blood of egyptian children with autism","volume":"25","author":"Mostafa","year":"2010","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.bbi.2019.07.022_b0250","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.3389\/fimmu.2018.01213","article-title":"Imbalance of circulating Th17 and regulatory T cells in alzheimer\u2019s disease: a case control study","volume":"9","author":"Oberstein","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbi.2019.07.022_b0255","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3109\/15622975.2015.1111524","article-title":"Association between genetic variants of serotonergic and glutamatergic pathways and the concentration of neurometabolites of the anterior cingulate cortex in paediatric patients with obsessive-compulsive disorder","volume":"17","author":"Ortiz","year":"2016","journal-title":"World J. Biol. Psychiatry"},{"key":"10.1016\/j.bbi.2019.07.022_b0260","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s00406-015-0642-9","article-title":"Clinical significance of psychiatric comorbidity in children and adolescents with obsessive-compulsive disorder: subtyping a complex disorder","volume":"266","author":"Ortiz","year":"2016","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.bbi.2019.07.022_b0265","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.neuroimage.2008.04.233","article-title":"In vivo PET study of 5HT2A serotonin and D2 dopamine dysfunction in drug-naive obsessive-compulsive disorder","volume":"42","author":"Perani","year":"2008","journal-title":"Neuroimage"},{"key":"10.1016\/j.bbi.2019.07.022_b0270","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.neubiorev.2016.09.025","article-title":"The link between autoimmune diseases and obsessive-compulsive and tic disorders: A systematic review","volume":"71","author":"P\u00e9rez-Vigil","year":"2016","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.bbi.2019.07.022_b0275","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.bbi.2016.12.020","article-title":"Th17 cells correlate positively to the structural and functional integrity of the brain in bipolar depression and healthy controls","volume":"61","author":"Poletti","year":"2017","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.bbi.2019.07.022_b0280","first-page":"1","article-title":"The role of peripheral immune cells in the CNS in steady state and disease","author":"Prinz","year":"2017","journal-title":"Nat. Neurosci. Adv."},{"key":"10.1016\/j.bbi.2019.07.022_b0285","article-title":"Regulatory T cell plasticity and stability and autoimmune diseases","author":"Qiu","year":"2018","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.bbi.2019.07.022_b0290","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.psychres.2015.07.009","article-title":"Plasma cytokine abnormalities in drug-naive, comorbidity-free obsessive-compulsive disorder","volume":"229","author":"Rao","year":"2015","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.bbi.2019.07.022_b0295","first-page":"1","article-title":"Human-leukocyte antigen class II genes in early- onset obsessive-compulsive disorder","volume":"31","author":"Rodr\u00edguez","year":"2017","journal-title":"World J. Biol. Psychiatry"},{"key":"10.1016\/j.bbi.2019.07.022_b0300","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1186\/s12974-017-1042-z","article-title":"Inflammatory dysregulation of monocytes in pediatric patients with obsessive-compulsive disorder","volume":"14","author":"Rodr\u00edguez","year":"2017","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.bbi.2019.07.022_b0305","doi-asserted-by":"crossref","unstructured":"Romagnani, S., 2000. T-cell subsets (Th1 versus Th2). Ann. Allergy, Asthma Immunol. 85, 9\u201318.","DOI":"10.1016\/S1081-1206(10)62426-X"},{"key":"10.1016\/j.bbi.2019.07.022_b0310","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1097\/00004583-200009000-00008","article-title":"Decrease in caudate glutamatergic concentrations in pediatric obsessive-compulsive disorder patients taking paroxetine","volume":"39","author":"Rosenberg","year":"2000","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.bbi.2019.07.022_b0315","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1136\/gut.2009.182170","article-title":"Differential regulation of interleukin 17 and interferon \u03b3 production in inflammatory bowel disease","volume":"58","author":"Rovedatti","year":"2009","journal-title":"Gut"},{"key":"10.1016\/j.bbi.2019.07.022_b0320","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/mp.2008.94","article-title":"The epidemiology of obsessive-compulsive disorder in the National Comorbidity Survey Replication","volume":"15","author":"Ruscio","year":"2010","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.bbi.2019.07.022_b0325","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/nri2785","article-title":"FOXP3 + regulatory T cells in the human immune system","volume":"10","author":"Sakaguchi","year":"2010","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bbi.2019.07.022_b0330","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1097\/00004583-199706000-00023","article-title":"Children\u2019s yale-brown obsessive compulsive scale: reliability and validity","volume":"36","author":"Scahill","year":"1997","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.bbi.2019.07.022_b0335","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ijnp\/pyw027","article-title":"Serum cytokine profiles of children with obsessive-compulsive disorder shows the evidence of autoimmunity","volume":"19","author":"\u015eim\u015fek","year":"2016","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.bbi.2019.07.022_b0340","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1600-0447.2004.00302.x","article-title":"Long-term outcome of pediatric obsessive-compulsive disorder: a meta-analysis and qualitative review of the literature","volume":"110","author":"Stewart","year":"2004","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.bbi.2019.07.022_b0345","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s00005-015-0344-z","article-title":"The role of IL-17 and Th17 lymphocytes in autoimmune diseases","volume":"63","author":"Tabarkiewicz","year":"2015","journal-title":"Arch. Immunol. Ther. Exp. (Warsz)"},{"key":"10.1016\/j.bbi.2019.07.022_b0350","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.pnpbp.2017.07.023","article-title":"The role of Th17 cells in auto-inflammatory neurological disorders","volume":"79","author":"Tahmasebinia","year":"2017","journal-title":"Prog. Neuro-Psychopharmacology Biol. Psychiatry"},{"key":"10.1016\/j.bbi.2019.07.022_b0355","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.cpr.2011.06.007","article-title":"Early versus late onset obsessive-compulsive disorder: evidence for distinct subtypes","volume":"31","author":"Taylor","year":"2011","journal-title":"Clin. Psychol. Rev."},{"key":"10.1016\/j.bbi.2019.07.022_b0360","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1159\/000356554","article-title":"Searching for the immune basis of obsessive-compulsive disorder","volume":"21","author":"Teixeira","year":"2014","journal-title":"Neuroimmunomodulation"},{"key":"10.1016\/j.bbi.2019.07.022_b0365","first-page":"36","article-title":"Interrater reliability of the Spanish version of schedule for affective disorders and schizophrenia for school-age children-present and lifetime version (K-SADS-PL)","volume":"34","author":"Ulloa","year":"2006","journal-title":"Actas Esp. Psiquiatr."},{"key":"10.1016\/j.bbi.2019.07.022_b0370","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1007\/s00296-010-1710-0","article-title":"The Th17\/Treg imbalance and cytokine environment in peripheral blood of patients with rheumatoid arthritis","volume":"32","author":"Wang","year":"2012","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.bbi.2019.07.022_b0375","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.immuni.2019.01.020","article-title":"Human FOXP3+ regulatory T cell heterogeneity and function in autoimmunity and cancer","volume":"50","author":"Wing","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.bbi.2019.07.022_b0380","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.pbb.2011.10.007","article-title":"The role of glutamate signalling in the pathogenesis and treatment of obsessive-compulsive disorder","volume":"100","author":"Wu","year":"2012","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.bbi.2019.07.022_b0385","doi-asserted-by":"crossref","first-page":"82390","DOI":"10.18632\/oncotarget.19326","article-title":"Immunological cytokine profiling identifies TNF- \u03b1 as a key molecule dysregulated in autistic children","volume":"8","author":"Xie","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbi.2019.07.022_b0390","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1007\/s10753-012-9496-8","article-title":"CD4+CD25+CD127low\/\u2212 T cells: a more specifictreg population in human peripheral blood","volume":"35","author":"Yu","year":"2012","journal-title":"Inflammation"},{"key":"10.1016\/j.bbi.2019.07.022_b0395","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1177\/039463201302600110","article-title":"Antidepressant drug, desipramine, alleviates allergic rhinitis by regulating Treg and Th17 cells","volume":"26","author":"Zhang","year":"2013","journal-title":"Int. J. Immunopathol. Pharmacol."}],"container-title":["Brain, Behavior, and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088915911930409X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088915911930409X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:57:55Z","timestamp":1760169475000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S088915911930409X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":79,"alternative-id":["S088915911930409X"],"URL":"https:\/\/doi.org\/10.1016\/j.bbi.2019.07.022","relation":{},"ISSN":["0889-1591"],"issn-type":[{"value":"0889-1591","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Altered frequencies of Th17 and Treg cells in children and adolescents with obsessive-compulsive disorder","name":"articletitle","label":"Article Title"},{"value":"Brain, Behavior, and Immunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbi.2019.07.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}